Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-04

FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's supplemental application for memantine hydrochloride, a generic form of the Alzheimer's disease therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

SUPPL AP for MEMANTINE HYDROCHLORIDE (MEMANTINE HYDROCHLORIDE)